Correlation Between Day One and Apogee Therapeutics,

Can any of the company-specific risk be diversified away by investing in both Day One and Apogee Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Day One and Apogee Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Day One Biopharmaceuticals and Apogee Therapeutics, Common, you can compare the effects of market volatilities on Day One and Apogee Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Day One with a short position of Apogee Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Day One and Apogee Therapeutics,.

Diversification Opportunities for Day One and Apogee Therapeutics,

0.69

Correlation Coefficient

Day One  Apogee Therapeutics,

Poor diversification

The 3 months correlation between Day and Apogee is 0.69. Overlapping area represents the amount of risk that can be diversified away by holding Day One Biopharmaceuticals and Apogee Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Apogee Therapeutics, and Day One is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Day One Biopharmaceuticals are associated (or correlated) with Apogee Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Apogee Therapeutics, has no effect on the direction of Day One i.e., Day One and Apogee Therapeutics, go up and down completely randomly.

Pair Corralation between Day One and Apogee Therapeutics,

Given the investment horizon of 90 days Day One Biopharmaceuticals is expected to generate 0.5 times more return on investment than Apogee Therapeutics,. However, Day One Biopharmaceuticals is 2.02 times less risky than Apogee Therapeutics,. It trades about -0.21 of its potential returns per unit of risk. Apogee Therapeutics, Common is currently generating about -0.11 per unit of risk. If you would invest  1,432  in Day One Biopharmaceuticals on September 15, 2024 and sell it today you would lose (157.00) from holding Day One Biopharmaceuticals or give up 10.96% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Day One Biopharmaceuticals  vs.  Apogee Therapeutics, Common

Day One Biopharmaceu

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Day One Biopharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Day One is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

Apogee Therapeutics,

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Apogee Therapeutics, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest inconsistent performance, the Stock's technical and fundamental indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.

Pair Trading with Day One and Apogee Therapeutics,

The main advantage of trading using opposite Day One and Apogee Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Day One position performs unexpectedly, Apogee Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Apogee Therapeutics, will offset losses from the drop in Apogee Therapeutics,'s long position.

The idea behind Day One Biopharmaceuticals and Apogee Therapeutics, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.